New Hepatitis C Drug Gives Patients More Choices and More Hope
Written by: Kristina Lybecker | Published:
Merck’s once-daily, single-tablet combination of grazoprevir and elbasvir proved effective in treating even the sickest hepatitis C patients, without negative side effects.